http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-102015031675-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a429eac3bfd2474ab5c3e1cebeb5972b |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-28 |
| filingDate | 2015-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8643bfd4b659a3ec86743a7d5e1dc19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d87fd955f02acdb9540f8b37efa2f4d8 |
| publicationDate | 2017-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | BR-102015031675-A2 |
| titleOfInvention | CONTROLLED CONVERSION HEMOCOMPHATABLE EPOXYDE FORMULATIONS AS A COATING COMPOSITION FOR MEDICAL DEVICES |
| abstract | Controlled Conversion Hemocompatible Epoxy Formulations as a Coating Composition for Medical Devices This invention discloses the obtaining of epoxy polymeric coatings with atoxic properties to the human body and compatible with blood for medical or biomedical engineering applications. polymeric coatings for medical devices may include at least one epoxy unit based on glycerol diglycidyl ether (dgeg) and at least one isophorone diamine (ipd) or 4,4'-diamino-3,3'-dimethyl dicyclohexylmethane unit (3dcm). The coatings may have at least one biologically compatible compound conjugated to or mixed with the polymer. Also disclosed are a process for producing such curable compositions comprising modified epoxy monomer and products provided with the cured composition, especially and coating applications in medical or biomedical engineering applications. |
| priorityDate | 2015-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 30.